Search research articles
Contact Us
Filters
Showing results (11-20 of 52) with videos related to
Page
of 6
Sort By:
Substance Abuse and Rehabilitation
|
August 27, 2025
Employment and Long-Acting Injectable Buprenorphine for Opioid Use Disorder: Findings from Longitudinal Qualitative Interviews Conducted with Patients Recruited from Drug Treatment Services
Joanne Neale, Sarah Cosgrove, James Cassidy, et al.
BMJ (Clinical Research Ed.)
|
November 30, 2002
Efficacy, safety, and cost of new anticancer drugs. Pessimistic conclusion was not justified
Hilary Calvert, Duncan I Jodrell, James Cassidy, et al.
Patient Related Outcome Measures
|
November 2, 2017
A pilot study of subjective well-being in colorectal cancer patients and their caregivers
Janet Graham, Pavlina Spiliopoulou, Rob Arbuckle, et al.
Chemical Communications (Cambridge, England)
|
September 7, 2023
Quantum shells <i>versus</i> quantum dots: suppressing Auger recombination in colloidal semiconductors
Jacob Beavon, Jiamin Huang, Dulanjan Harankahage, et al.
Nano Letters
|
May 26, 2021
Photoinduced Rotation of Colloidal Semiconductor Nanocrystals in an Electric Field
Dmitry Porotnikov, Dulanjan Harankahage, Cole Ellison, et al.
Cancer Research
|
November 19, 2004
Mechanistic and predictive profiling of 5-Fluorouracil resistance in human cancer cells
Weiguang Wang, James Cassidy, Vincent O'Brien, et al.
Cancer Chemotherapy and Pharmacology
|
November 23, 2006
Mechanisms of acquired chemoresistance to 5-fluorouracil and tomudex: thymidylate synthase dependent and independent networks
Weiguang Wang, Howard L McLeod, James Cassidy, et al.
Nano Letters
|
July 3, 2025
Evaluating Brightness and Stability of Cathodoluminescence from Colloidal Semiconductor Nanocrystals
Benjamin T Diroll, Robert Sevik, Muchuan Hua, et al.
Investigational New Drugs
|
May 19, 2011
Safety and tolerability of the poly(ADP-ribose) polymerase (PARP) inhibitor, olaparib (AZD2281) in combination with topotecan for the treatment of patients with advanced solid tumors: a phase I study
Jens Samol, Malcolm Ranson, Edwina Scott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 2005
Phase I study of OSI-7904L, a novel liposomal thymidylate synthase inhibitor in patients with refractory solid tumors
Gernot Beutel, Hilary Glen, Patrick Schöffski, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 52) with videos related to
Sort By:
Page
of 6
Substance Abuse and Rehabilitation
|
August 27, 2025
Employment and Long-Acting Injectable Buprenorphine for Opioid Use Disorder: Findings from Longitudinal Qualitative Interviews Conducted with Patients Recruited from Drug Treatment Services
Joanne Neale, Sarah Cosgrove, James Cassidy, et al.
BMJ (Clinical Research Ed.)
|
November 30, 2002
Efficacy, safety, and cost of new anticancer drugs. Pessimistic conclusion was not justified
Hilary Calvert, Duncan I Jodrell, James Cassidy, et al.
Patient Related Outcome Measures
|
November 2, 2017
A pilot study of subjective well-being in colorectal cancer patients and their caregivers
Janet Graham, Pavlina Spiliopoulou, Rob Arbuckle, et al.
Chemical Communications (Cambridge, England)
|
September 7, 2023
Quantum shells <i>versus</i> quantum dots: suppressing Auger recombination in colloidal semiconductors
Jacob Beavon, Jiamin Huang, Dulanjan Harankahage, et al.
Nano Letters
|
May 26, 2021
Photoinduced Rotation of Colloidal Semiconductor Nanocrystals in an Electric Field
Dmitry Porotnikov, Dulanjan Harankahage, Cole Ellison, et al.
Cancer Research
|
November 19, 2004
Mechanistic and predictive profiling of 5-Fluorouracil resistance in human cancer cells
Weiguang Wang, James Cassidy, Vincent O'Brien, et al.
Cancer Chemotherapy and Pharmacology
|
November 23, 2006
Mechanisms of acquired chemoresistance to 5-fluorouracil and tomudex: thymidylate synthase dependent and independent networks
Weiguang Wang, Howard L McLeod, James Cassidy, et al.
Nano Letters
|
July 3, 2025
Evaluating Brightness and Stability of Cathodoluminescence from Colloidal Semiconductor Nanocrystals
Benjamin T Diroll, Robert Sevik, Muchuan Hua, et al.
Investigational New Drugs
|
May 19, 2011
Safety and tolerability of the poly(ADP-ribose) polymerase (PARP) inhibitor, olaparib (AZD2281) in combination with topotecan for the treatment of patients with advanced solid tumors: a phase I study
Jens Samol, Malcolm Ranson, Edwina Scott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 2005
Phase I study of OSI-7904L, a novel liposomal thymidylate synthase inhibitor in patients with refractory solid tumors
Gernot Beutel, Hilary Glen, Patrick Schöffski, et al.
Page
of 6